Demo Sign up Log In

Ligand Pharmaceuticals Inc (LGND)

Operating Expenses

$51.89M

Quarterly · Period ending: Jun 30, 2026 · USD

LGND Operating Expenses

Latest reported$51.89Mperiod endingJun 30, 2026

Latest reported$51.89Mperiod endingJun 30, 2026

LGND Quarterly Operating Expenses ($2.00M → $51.89M)

Quarterly operating expenses

High-resolution chart · PNG

LGND operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Operating Expenses — Quarterly (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2001	23,014,000
Mar 31, 2001	23,498,000
Dec 31, 2000	15,380,000
Sep 30, 2000	25,915,000
Jun 30, 2000	26,365,000
Mar 31, 2000	24,713,000
Dec 31, 1999	18,600,000
Sep 30, 1999	25,800,000
Jun 30, 1999	26,200,000
Mar 31, 1999	23,500,000
Dec 31, 1998	30,500,000
Sep 30, 1998	22,600,000
Jun 30, 1998	22,400,000
Mar 31, 1998	19,500,000
Dec 31, 1997	26,400,000
Sep 30, 1997	23,000,000
Jun 30, 1997	21,600,000
Mar 31, 1997	21,200,000
Dec 31, 1996	22,700,000
Sep 30, 1996	21,700,000
Jun 30, 1996	18,600,000
Mar 31, 1996	16,000,000
Dec 31, 1995	16,500,000
Sep 30, 1995	15,200,000
Jun 30, 1995	0
Mar 31, 1995	9,400,000
Dec 31, 1994	3,400,000
Sep 30, 1994	2,100,000
Jun 30, 1994	2,000,000
Mar 31, 1994	2,000,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.